Skip to main content
. Author manuscript; available in PMC: 2013 May 15.
Published in final edited form as: Circulation. 2012 Apr 17;125(19):2316–2322. doi: 10.1161/CIRCULATIONAHA.111.072751

Table 2.

Association of Fetuin-A with Incident Diabetes in the Cardiovascular Health Study

Range (g/L) Fetuin-A Quartiles
Continuous
I II III IV Per SD (0.10 g/L) greater
≤0.41 >0.41–0.47 >0.47–0.53 >0.53 P-value
Events/ Person Years at Risk 56/8811 71/8913 93/8989 85/8670
Model 1*; HR (95% CI) 1.00 (Ref) 1.31 (0.92–1.87) 1.75 (1.25–2.45) 1.69 (1.20–2.40) 1.23 (1.09–1.38) 0.001
Model 2**; HR (95% CI) 1.00 (Ref) 1.27 (0.89–1.80) 1.72 (1.23–2.41) 1.56 (1.10–2.21) 1.19 (1.06–1.34) 0.003
Model 3; HR (95% CI) 1.00 (Ref) 1.16 (0.81–1.65) 1.52 (1.08–2.13) 1.37 (0.95–1.96) 1.13 (1.00–1.28) 0.05

Abbreviations: HR=Hazard Ratio; CI=confidence interval; Ref=reference category

*

Model 1 is adjusted for age, sex, race, and field center site

**

Model 2 is adjusted for model 1 variables plus physical activity, smoking, alcohol use, eGFR, and prevalent CVD

Model 3 is adjusted for model 2 variables plus body mass index, waist circumference, hypertension, triglycerides, HDL, serum albumin, and CRP.